Alliance Pharma PLC has announced that the preliminary results for the year ended 31 December 2023 will be published on 8 May 2024. The company will hold a meeting for analysts at 9.30am on the day of the results at Buchanan, 107 Cheapside, London. A live webcast of the analyst meeting will be accessible via a provided link, and a recording of the webcast will be made available following the meeting at the investor section of Alliance's website.

Alliance Pharma plc (AIM: APH) is a growing consumer healthcare company with the purpose of empowering people to make a positive difference to their health and wellbeing by making trusted and proven brands available around the world. The company delivers organic growth through investing in priority brands and channels, related innovation, and selective geographic expansion to increase the reach of its brands. The Group employs around 285 people based in locations across Europe, North America, and the Asia Pacific region and remains asset-light by outsourcing manufacturing and logistics.

For further information, interested parties can contact Alliance Pharma plc or Buchanan, the company's contact for the analyst meeting. Additionally, the company's Nominated Adviser and Joint Broker, as well as Joint Broker, are available for further inquiries.